SELPERCATINIB, Selpercatinib, Selpercatinib, SELPERCATINIB, Selpercatinib
LOXO-RET-18036
Phase 2 small_molecule active
Quick answer
SELPERCATINIB, Selpercatinib, Selpercatinib, SELPERCATINIB, Selpercatinib for Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active